Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis.
Zhang, Junfen, Loman, Laura, Oldhoff, Jantje M et al. · Acta dermato-venereologica · 2023 · DOI
Quick Summary
This study found that adults with moderate-to-severe atopic dermatitis (a chronic skin condition causing itching and inflammation) were more likely to experience loneliness and several psychiatric conditions, including panic disorder, anxiety, depression, and chronic fatigue syndrome. The associations were strongest in people with more severe skin disease, while those with mild atopic dermatitis did not show these increased risks. The researchers suggest that doctors treating skin conditions should also consider screening for and addressing mental health concerns.
Why It Matters
This study is relevant to ME/CFS patients because it documents a significant association between a chronic inflammatory condition (atopic dermatitis) and chronic fatigue syndrome, suggesting shared psychiatric and psychological comorbidities across chronic conditions. The emphasis on interdisciplinary care and the need to address psychiatric and psychosocial factors alongside physical symptoms parallels important considerations in ME/CFS management. The finding that severe disease burden correlates more strongly with psychiatric comorbidities highlights the importance of addressing both disease severity and mental health in complex chronic conditions.
Observed Findings
Moderate-to-severe atopic dermatitis was positively associated with self-reported lifetime chronic fatigue syndrome, burnout, depression, social phobia, panic disorder, ADHD, and eating disorders.
Adults with atopic dermatitis showed significantly higher rates of panic disorder and at least one anxiety disorder on validated psychiatric assessment (M.I.N.I.).
Patients with atopic dermatitis reported greater loneliness compared to those without atopic dermatitis.
Associations between atopic dermatitis and psychiatric/psychological outcomes were observed only in the moderate-to-severe group, not in the mild atopic dermatitis group.
The study included 56,896 participants with a mean age of 55.8 years, with 39.7% males.
Inferred Conclusions
A significant proportion of adults with moderate-to-severe atopic dermatitis experience psychiatric comorbidities and loneliness, suggesting they represent a vulnerable population requiring enhanced clinical attention.
Disease severity appears to be a key factor in the psychiatric and psychological burden associated with atopic dermatitis.
Interdisciplinary collaboration between dermatologists and mental health professionals may be necessary to optimize care for adults with moderate-to-severe atopic dermatitis.
Remaining Questions
Does atopic dermatitis severity cause psychiatric disorders and loneliness, or do these conditions share common underlying mechanisms?
What This Study Does Not Prove
This study does not prove that atopic dermatitis causes psychiatric disorders or loneliness—it only shows they occur together more frequently. The cross-sectional design captures associations at a single time point and cannot establish the direction or temporal sequence of causality. Additionally, the study relies heavily on self-reported psychiatric symptoms rather than comprehensive clinical diagnoses, which may overestimate or underestimate true disorder prevalence.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
How do these associations develop over time, and what is the temporal relationship between skin disease onset and psychiatric symptom emergence?
Would interdisciplinary treatment involving dermatology and psychiatry improve outcomes, and if so, which psychiatric interventions are most effective in this population?
Are the associations between atopic dermatitis and chronic fatigue syndrome direct, or mediated by shared factors such as inflammation or immune dysfunction?